Dr. Michael Davidson, a nationally recognized cardiologist and clinical lipidologist, will lead a targeted discussion focusing on the interpretation and application of results presented at this year's AHA meeting. Joining him will be a distinguished faculty panel, including: Dr. Christie Ballantyne, Director of the Center for Cardiovascular Disease Prevention at Baylor College of Medicine; Dr. Vera Bittner, Section Head of Preventive Cardiology at the University of Alabama at Birmingham and President of the National Lipid Association; and Dr. Roger Blumenthal, Director of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease.

Join Drs. Blumenthal and Ridker as they inform our community about upcoming consensus guidelines which will address this current medical debate, as well as the limitations of existing treatments as they formulate their management strategies.

Join our panel of experts, Drs Ridker, Blumenthal, Ballantyne, and Wilson as they discuss the pathophysiology of inflammation as it relates to the development and progression of CVD and how systemic inflammation biomarkers can be used as surrogate endpoints in clinical trials of therapeutic agents.